Claudio Martines

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Blood advances

Blood

British journal of pharmacology

International Centre for Genetic Engineering and Biotechnology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

International Centre for Genetic Engineering and Biotechnology Oct 01 2018

Italy

PhD :: Molecular Hematology

Publications

Vincenzo G Messana, Amelia Fascì, Nicoletta Vitale, Matilde Micillo, Matteo Rovere, Noemi Anna Pesce, Claudio Martines, Dimitar G Efremov, Tiziana Vaisitti, Silvia Deaglio
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome. Blood advances 8 (8) (2024)
Vincenzo G Messana, Amelia Fascì, Nicoletta Vitale, Matilde Micillo, Matteo Rovere, Noemi Anna Pesce, Claudio Martines, Dimitar G Efremov, Tiziana Vaisitti, Silvia Deaglio
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome. Blood advances 8 (8) (2024)
Vincenzo G Messana, Amelia Fascì, Nicoletta Vitale, Matilde Micillo, Matteo Rovere, Noemi Anna Pesce, Claudio Martines, Dimitar G Efremov, Tiziana Vaisitti, Silvia Deaglio
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome. Blood advances 8 (8) (2024)
Vincenzo Gianluca Messana, Amelia Fascì, Nicoletta Vitale, Matilde Micillo, Matteo Rovere, Noemi Anna Pesce, Claudio Martines, Dimitar G Efremov, Tiziana Vaisitti, Silvia Deaglio
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter's syndrome. Blood advances (2024)
Claudio Martines, Supriya Chakraborty, Marija Vujovikj, Stefania Gobessi, Tiziana Vaisitti, Silvia Deaglio, Luca Laurenti, Aleksandar J Dimovski, Dimitar G Efremov
Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo. Blood 140 (22) (2022)
Supriya Chakraborty, Claudio Martines, Fabiola Porro, Ilaria Fortunati, Alice Bonato, Marija Dimishkovska, Silvano Piazza, Brijesh Singh Yadav, Idanna Innocenti, Rosa Fazio, Tiziana Vaisitti, Silvia Deaglio, Alberto Zamo, Aleksandar J Dimovski, Luca Laurenti, Dimitar G Efremov
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation. Blood 138 (12) (2021)
Monika A Jakubowska, Martijn Kerkhofs, Claudio Martines, Dimitar G Efremov, Julia V Gerasimenko, Oleg V Gerasimenko, Ole H Petersen, Geert Bultynck, Tim Vervliet, Pawel E Ferdek
ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. British journal of pharmacology 176 (22) (2018)

Claudio Martines.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Claudio Martines